Aurinia Pharmaceuticals
AUPH
AUPH
196 hedge funds and large institutions have $391M invested in Aurinia Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 68 increasing their positions, 48 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% less funds holding
Funds holding: 198 → 196 (-2)
19% less capital invested
Capital invested by funds: $483M → $391M (-$91.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
196
Holding in Top 10
–
Calls
$23.6M
Puts
$14.2M
Top Buyers
| 1 | +$18.3M | |
| 2 | +$10.5M | |
| 3 | +$4.66M | |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$3.62M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$2.31M |
Top Sellers
| 1 | -$6.74M | |
| 2 | -$5.75M | |
| 3 | -$5.27M | |
| 4 |
AC
Antara Capital
New York
|
-$4.84M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.22M |